logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Poynter, Caroline
    Born in May 1964
    Individual (10 offsprings)
    Officer
    icon of calendar 2018-08-28 ~ now
    OF - Director → CIF 0
  • 2
    Pritchard, Ian
    Born in December 1969
    Individual (23 offsprings)
    Officer
    icon of calendar 2019-08-05 ~ now
    OF - Director → CIF 0
  • 3
    Yates, Jason Derick
    Born in June 1973
    Individual (20 offsprings)
    Officer
    icon of calendar 2018-08-28 ~ now
    OF - Director → CIF 0
  • 4
    Falzon, Carl Robert
    Born in June 1977
    Individual (7 offsprings)
    Officer
    icon of calendar 2018-08-28 ~ now
    OF - Director → CIF 0
  • 5
    C.S.T. PHARMA GROUP HOLDINGS LIMITED - now
    ST TOPCO (UK) LIMITED - 2019-11-06
    icon of address5-7, 5 - 7 Tintagel Way, Aldridge, Aldridge, Walsall, West Midlands, United Kingdom
    Active Corporate (4 parents, 8 offsprings)
    Profit/Loss (Company account)
    911,544 GBP2023-05-01 ~ 2024-04-30
    Person with significant control
    icon of calendar 2025-04-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 7
  • 1
    Troman, Catherine Anne
    Business Executive born in December 1970
    Individual (2 offsprings)
    Officer
    icon of calendar 2001-05-09 ~ 2008-07-31
    OF - Director → CIF 0
    Troman, Catherine
    Company Director born in December 1970
    Individual (2 offsprings)
    Officer
    icon of calendar 2010-12-01 ~ 2018-08-28
    OF - Director → CIF 0
  • 2
    Wheeler, George James
    Company Director born in June 1937
    Individual (1 offspring)
    Officer
    icon of calendar 2008-07-31 ~ 2010-04-01
    OF - Director → CIF 0
  • 3
    Troman, Stephen
    Business Executive born in November 1967
    Individual (1 offspring)
    Officer
    icon of calendar 2001-05-09 ~ 2002-08-06
    OF - Director → CIF 0
    Troman, Stephen
    Director born in November 1967
    Individual (1 offspring)
    icon of calendar 2003-05-23 ~ 2008-07-31
    OF - Director → CIF 0
    icon of calendar 2010-09-20 ~ 2017-05-01
    OF - Director → CIF 0
    Troman, Stephen
    Director
    Individual (1 offspring)
    Officer
    icon of calendar 2001-05-09 ~ 2008-07-31
    OF - Secretary → CIF 0
  • 4
    Grenan, Michelle
    Quality Director born in May 1969
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-05-01 ~ 2023-01-30
    OF - Director → CIF 0
  • 5
    Thomas, Howard
    Individual (4 offsprings)
    Officer
    icon of calendar 2001-05-09 ~ 2001-05-09
    OF - Nominee Secretary → CIF 0
  • 6
    O'connor, Daniel Mark
    Company Director born in September 1981
    Individual (3 offsprings)
    Officer
    icon of calendar 2008-07-31 ~ 2019-05-21
    OF - Director → CIF 0
  • 7
    icon of addressUnit 5-7, Tintagel Way, Aldridge, Walsall, England
    Dissolved Corporate (5 parents, 4 offsprings)
    Equity (Company account)
    20,813 GBP2024-04-30
    Person with significant control
    2017-05-09 ~ 2025-04-01
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

C. S. T. PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Cost of Sales
-74,155,301 GBP2023-05-01 ~ 2024-04-30
-101,718,430 GBP2022-05-01 ~ 2023-04-30
Administrative Expenses
-7,281,841 GBP2023-05-01 ~ 2024-04-30
-7,910,358 GBP2022-05-01 ~ 2023-04-30
Profit/Loss on Ordinary Activities Before Tax
2,400,674 GBP2023-05-01 ~ 2024-04-30
2,875,703 GBP2022-05-01 ~ 2023-04-30
Profit/Loss
1,865,026 GBP2023-05-01 ~ 2024-04-30
2,410,758 GBP2022-05-01 ~ 2023-04-30
Intangible Assets
Other
511,063 GBP2024-04-30
490,094 GBP2023-04-30
Property, Plant & Equipment
1,755,736 GBP2024-04-30
1,245,402 GBP2023-04-30
Fixed Assets
2,266,799 GBP2024-04-30
1,735,496 GBP2023-04-30
Debtors
17,622,152 GBP2024-04-30
16,572,083 GBP2023-04-30
Cash at bank and in hand
287,877 GBP2024-04-30
137,603 GBP2023-04-30
Current Assets
30,953,215 GBP2024-04-30
28,837,997 GBP2023-04-30
Net Current Assets/Liabilities
11,826,786 GBP2024-04-30
10,505,230 GBP2023-04-30
Total Assets Less Current Liabilities
14,093,585 GBP2024-04-30
12,240,726 GBP2023-04-30
Creditors
Non-current, Amounts falling due after one year
-333,820 GBP2024-04-30
Net Assets/Liabilities
13,759,765 GBP2024-04-30
12,123,970 GBP2023-04-30
Equity
Called up share capital
100 GBP2024-04-30
100 GBP2023-04-30
Retained earnings (accumulated losses)
13,759,665 GBP2024-04-30
12,123,870 GBP2023-04-30
Equity
13,759,765 GBP2024-04-30
12,123,970 GBP2023-04-30
Profit/Loss
Retained earnings (accumulated losses)
1,865,026 GBP2023-05-01 ~ 2024-04-30
2,410,758 GBP2022-05-01 ~ 2023-04-30
Dividends Paid
Retained earnings (accumulated losses)
-229,095 GBP2022-05-01 ~ 2023-04-30
Dividends Paid
-229,231 GBP2023-05-01 ~ 2024-04-30
Audit Fees/Expenses
16,000 GBP2023-05-01 ~ 2024-04-30
25,240 GBP2022-05-01 ~ 2023-04-30
Average Number of Employees
1172023-05-01 ~ 2024-04-30
1312022-05-01 ~ 2023-04-30
Wages/Salaries
3,764,209 GBP2023-05-01 ~ 2024-04-30
3,762,287 GBP2022-05-01 ~ 2023-04-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
98,603 GBP2023-05-01 ~ 2024-04-30
128,141 GBP2022-05-01 ~ 2023-04-30
Staff Costs/Employee Benefits Expense
4,353,937 GBP2023-05-01 ~ 2024-04-30
4,389,754 GBP2022-05-01 ~ 2023-04-30
Director Remuneration
218,874 GBP2023-05-01 ~ 2024-04-30
457,589 GBP2022-05-01 ~ 2023-04-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
0 GBP2023-05-01 ~ 2024-04-30
-44,888 GBP2022-05-01 ~ 2023-04-30
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
1,225,184 GBP2024-04-30
1,000,074 GBP2023-04-30
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
714,121 GBP2024-04-30
509,980 GBP2023-04-30
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
204,141 GBP2023-05-01 ~ 2024-04-30
Intangible Assets
Patents/Trademarks/Licences/Concessions
511,063 GBP2024-04-30
490,094 GBP2023-04-30
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
605,353 GBP2024-04-30
546,628 GBP2023-04-30
Plant and equipment
1,262,436 GBP2024-04-30
1,069,936 GBP2023-04-30
Computers
933,772 GBP2024-04-30
845,231 GBP2023-04-30
Motor vehicles
843,324 GBP2024-04-30
330,973 GBP2023-04-30
Property, Plant & Equipment - Gross Cost
3,644,885 GBP2024-04-30
2,792,768 GBP2023-04-30
Property, Plant & Equipment - Other Disposals
Plant and equipment
0 GBP2023-05-01 ~ 2024-04-30
Computers
0 GBP2023-05-01 ~ 2024-04-30
Motor vehicles
-27,025 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals
-27,025 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
322,474 GBP2024-04-30
233,198 GBP2023-04-30
Plant and equipment
940,043 GBP2024-04-30
836,611 GBP2023-04-30
Computers
408,381 GBP2024-04-30
313,793 GBP2023-04-30
Motor vehicles
218,251 GBP2024-04-30
163,764 GBP2023-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,889,149 GBP2024-04-30
1,547,366 GBP2023-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Under hire purchased contracts or finance leases
89,276 GBP2023-05-01 ~ 2024-04-30
Plant and equipment
103,432 GBP2023-05-01 ~ 2024-04-30
Computers
94,588 GBP2023-05-01 ~ 2024-04-30
Motor vehicles
81,507 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
368,803 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
0 GBP2023-05-01 ~ 2024-04-30
Computers
0 GBP2023-05-01 ~ 2024-04-30
Motor vehicles
-27,020 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-27,020 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment
Land and buildings, Under hire purchased contracts or finance leases
282,879 GBP2024-04-30
313,430 GBP2023-04-30
Plant and equipment
322,393 GBP2024-04-30
233,325 GBP2023-04-30
Computers
525,391 GBP2024-04-30
531,438 GBP2023-04-30
Motor vehicles
625,073 GBP2024-04-30
167,209 GBP2023-04-30
Finished Goods/Goods for Resale
13,043,186 GBP2024-04-30
12,128,311 GBP2023-04-30
Trade Debtors/Trade Receivables
Current
10,875,213 GBP2024-04-30
12,111,492 GBP2023-04-30
Amounts Owed by Group Undertakings
Current
4,678,829 GBP2024-04-30
2,817,143 GBP2023-04-30
Other Debtors
Current
162,710 GBP2024-04-30
170,365 GBP2023-04-30
Prepayments/Accrued Income
Current
367,006 GBP2024-04-30
563,915 GBP2023-04-30
Debtors
Amounts falling due within one year, Current
17,622,152 GBP2024-04-30
16,572,083 GBP2023-04-30
Finance Lease Liabilities - Total Present Value
Current
169,887 GBP2024-04-30
72,374 GBP2023-04-30
Trade Creditors/Trade Payables
Current
2,728,903 GBP2024-04-30
3,276,898 GBP2023-04-30
Amounts owed to group undertakings
Current
100 GBP2024-04-30
854 GBP2023-04-30
Corporation Tax Payable
Current
295,306 GBP2024-04-30
164,817 GBP2023-04-30
Other Taxation & Social Security Payable
Current
1,252,434 GBP2024-04-30
1,650,842 GBP2023-04-30
Other Creditors
Current
12,185,767 GBP2024-04-30
12,891,628 GBP2023-04-30
Accrued Liabilities/Deferred Income
Current
300,509 GBP2024-04-30
275,354 GBP2023-04-30
Creditors
Current
19,126,429 GBP2024-04-30
18,332,767 GBP2023-04-30
Finance Lease Liabilities - Total Present Value
Non-current
333,820 GBP2024-04-30
116,756 GBP2023-04-30
Minimum gross finance lease payments owing
Amounts falling due within one year
169,887 GBP2024-04-30
72,374 GBP2023-04-30
Minimum gross finance lease payments owing
503,707 GBP2024-04-30
189,130 GBP2023-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
188,967 GBP2024-04-30
219,532 GBP2023-04-30
Between two and five year
751,080 GBP2024-04-30
755,820 GBP2023-04-30
More than five year
391,188 GBP2024-04-30
578,958 GBP2023-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
1,331,235 GBP2024-04-30
1,554,310 GBP2023-04-30
Related profiles found in government register
  • C. S. T. PHARMA LIMITED
    Info
    Registered number 04212740
    icon of addressUnit 5-7 Tintagel Way, Westgate Park Industrial Estate Aldridge, Walsall WS9 8ER
    PRIVATE LIMITED COMPANY incorporated on 2001-05-09 (24 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-09
    CIF 0
  • CST PHARMA LIMITED
    S
    Registered number 04212740
    icon of addressUnit 5-7, Tintagel Way, Aldridge, Walsall, United Kingdom, WS9 8ER
    ENGLAND & WALES
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • icon of addressUnit 5-7 Tintagel Way, Aldridge, Walsall
    Active Corporate (4 parents)
    Equity (Company account)
    100 GBP2024-04-30
    Officer
    icon of calendar 2012-10-31 ~ 2012-12-01
    CIF 1 - Director → ME

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.